Stock listing

Beijing Beilu Pharmaceutical Co., Ltd. Class A

Selected listing: 300016 · SZSE · CNY · CN

Beijing Beilu Pharmaceutical Co., Ltd. Class A (Shenzhen:300016), Health Technology. Latest release Sep 20, 2026: Beijing Beilu Says Bimatoprost Ophthalmic…

300016:SZSECNYCNUpdated October 2, 2026
Beijing Beilu Pharmaceutical Co., Ltd. Class A logo
Ticker
Shenzhen:300016
Asset type
Stock
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
Shenzhen
Currency
CNY

About Beijing Beilu Pharmaceutical Co., Ltd. Class A

Beijing Beilu Pharmaceutical Co., Ltd. Class A, traded under the ticker 300016, is a public company operating in the pharmaceutical sector in China. It focuses on the development and production of pharmaceutical products to meet healthcare needs in the region.

Latest news from Beijing Beilu Pharmaceutical Co., Ltd. Class A

Beijing Beilu Says Bimatoprost Ophthalmic Solution Receives Drug Registration Certificate

September 20, 2026

All Beijing Beilu Pharmaceutical Co., Ltd. Class A news →

Research Beijing Beilu Pharmaceutical Co., Ltd. Class A

Beijing Beilu Pharmaceutical Co., Ltd. Class A company profile

View the public company page for Beijing Beilu Pharmaceutical Co., Ltd. Class A on 6ix.

Beijing Beilu Pharmaceutical Co., Ltd. Class A news

Read company news and market updates connected to Beijing Beilu Pharmaceutical Co., Ltd. Class A.

Beijing Beilu Pharmaceutical Co., Ltd. Class A investor events

Find investor webinars, events, and replay context for Beijing Beilu Pharmaceutical Co., Ltd. Class A.